Tuberous sclerosis is associated with epilepsy in up to 85% of cases, and in 2/3, the onset is within the first year of life. An early antiepileptic treatment is crucial to minimize the consequences of epilepsy on cognition and behavior. We present a case report of a child with tuberous sclerosis who presented with infantile spasms at the age of 6 months, immediately treated with vigabatrin. Because of the presence of a subependymal giant cell astrocytoma, he also received everolimus since 18 months of age. We might wonder if an earlier treatment could have produced a better outcome; in fact, despite a targeted combined treatment, he continues to suffer from sporadic focal motor seizures, and at the age of 40 months, he presents severe deve...
Objective: Tuberous sclerosis complex is expressed throughout the body, resulting in a range of clin...
Objective To study the association between timing and characteristics of the first electroencephalog...
AbstractBackgroundEpilepsy appears in 70–80% of patients with tuberous sclerosis complex, most commo...
Tuberous sclerosis is associated with epilepsy in up to 85% of cases, and in 2/3, the onset is withi...
AbstractTuberous sclerosis is associated with epilepsy in up to 85% of cases, and in 2/3, the onset ...
Seizures are clinically significant manifestations associated with 79%-90% of patients with tuberous...
Objective: To evaluate the relationship between age at seizure onset and neurodevelopmental outcome ...
Epilepsy affects 75% to 90% of people with tuberous sclerosis, a multisystem genetic disorder. Altho...
Patients with tuberous sclerosis complex (TSC) are at very high risk for developing epilepsy, and th...
Objective Epilepsy develops in 70 to 90% of children with tuberous sclerosis complex (TSC) and is of...
Abstract Background Tuberous sclerosis complex (TSC) is a genetic disorder with an incidence of 1:60...
Objective: Tuberous sclerosis complex is expressed throughout the body, resulting in a range of clin...
Objective To study the association between timing and characteristics of the first electroencephalog...
AbstractBackgroundEpilepsy appears in 70–80% of patients with tuberous sclerosis complex, most commo...
Tuberous sclerosis is associated with epilepsy in up to 85% of cases, and in 2/3, the onset is withi...
AbstractTuberous sclerosis is associated with epilepsy in up to 85% of cases, and in 2/3, the onset ...
Seizures are clinically significant manifestations associated with 79%-90% of patients with tuberous...
Objective: To evaluate the relationship between age at seizure onset and neurodevelopmental outcome ...
Epilepsy affects 75% to 90% of people with tuberous sclerosis, a multisystem genetic disorder. Altho...
Patients with tuberous sclerosis complex (TSC) are at very high risk for developing epilepsy, and th...
Objective Epilepsy develops in 70 to 90% of children with tuberous sclerosis complex (TSC) and is of...
Abstract Background Tuberous sclerosis complex (TSC) is a genetic disorder with an incidence of 1:60...
Objective: Tuberous sclerosis complex is expressed throughout the body, resulting in a range of clin...
Objective To study the association between timing and characteristics of the first electroencephalog...
AbstractBackgroundEpilepsy appears in 70–80% of patients with tuberous sclerosis complex, most commo...